Literature DB >> 25471947

Radiotherapy beyond cancer: target localization in real-time MRI and treatment planning for cardiac radiosurgery.

S Ipsen1, O Blanck2, B Oborn3, F Bode4, G Liney5, P Hunold6, D Rades2, A Schweikard7, P J Keall8.   

Abstract

PURPOSE: Atrial fibrillation (AFib) is the most common cardiac arrhythmia that affects millions of patients world-wide. AFib is usually treated with minimally invasive, time consuming catheter ablation techniques. While recently noninvasive radiosurgery to the pulmonary vein antrum (PVA) in the left atrium has been proposed for AFib treatment, precise target location during treatment is challenging due to complex respiratory and cardiac motion. A MRI linear accelerator (MRI-Linac) could solve the problems of motion tracking and compensation using real-time image guidance. In this study, the authors quantified target motion ranges on cardiac magnetic resonance imaging (MRI) and analyzed the dosimetric benefits of margin reduction assuming real-time motion compensation was applied.
METHODS: For the imaging study, six human subjects underwent real-time cardiac MRI under free breathing. The target motion was analyzed retrospectively using a template matching algorithm. The planning study was conducted on a CT of an AFib patient with a centrally located esophagus undergoing catheter ablation, representing an ideal case for cardiac radiosurgery. The target definition was similar to the ablation lesions at the PVA created during catheter treatment. Safety margins of 0 mm (perfect tracking) to 8 mm (untracked respiratory motion) were added to the target, defining the planning target volume (PTV). For each margin, a 30 Gy single fraction IMRT plan was generated. Additionally, the influence of 1 and 3 T magnetic fields on the treatment beam delivery was simulated using Monte Carlo calculations to determine the dosimetric impact of MRI guidance for two different Linac positions.
RESULTS: Real-time cardiac MRI showed mean respiratory target motion of 10.2 mm (superior-inferior), 2.4 mm (anterior-posterior), and 2 mm (left-right). The planning study showed that increasing safety margins to encompass untracked respiratory motion leads to overlapping structures even in the ideal scenario, compromising either normal tissue dose constraints or PTV coverage. The magnetic field caused a slight increase in the PTV dose with the in-line MRI-Linac configuration.
CONCLUSIONS: The authors' results indicate that real-time tracking and motion compensation are mandatory for cardiac radiosurgery and MRI-guidance is feasible, opening the possibility of treating cardiac arrhythmia patients completely noninvasively.

Entities:  

Mesh:

Year:  2014        PMID: 25471947     DOI: 10.1118/1.4901414

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  15 in total

Review 1.  Magnetic resonance image guidance in external beam radiation therapy planning and delivery.

Authors:  Ilamurugu Arivarasan; Chandrasekaran Anuradha; Shanmuga Subramanian; Ayyalusamy Anantharaman; Velayudham Ramasubramanian
Journal:  Jpn J Radiol       Date:  2017-06-13       Impact factor: 2.374

2.  A Novel Respiratory Motion Perturbation Model Adaptable to Patient Breathing Irregularities.

Authors:  Amy Yuan; Jie Wei; Carl P Gaebler; Hailiang Huang; Devin Olek; Guang Li
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-03       Impact factor: 7.038

Review 3.  Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.

Authors:  John Alan Gambril; Aaron Chum; Akash Goyal; Patrick Ruz; Katarzyna Mikrut; Orlando Simonetti; Hardeep Dholiya; Brijesh Patel; Daniel Addison
Journal:  Heart Fail Clin       Date:  2022-07       Impact factor: 2.828

4.  Stereotactic Radiotherapy Ablation and Atrial Fibrillation: Technical Issues and Clinical Expectations Derived From a Systematic Review.

Authors:  Jessica Franzetti; Stefania Volpe; Valentina Catto; Edoardo Conte; Consiglia Piccolo; Matteo Pepa; Gaia Piperno; Anna Maria Camarda; Federica Cattani; Daniele Andreini; Claudio Tondo; Barbara Alicja Jereczek-Fossa; Corrado Carbucicchio
Journal:  Front Cardiovasc Med       Date:  2022-05-03

5.  A Treatment Planning Study of Stereotactic Body Radiotherapy for Atrial Fibrillation.

Authors:  Ping Xia; Rupesh Kotecha; Naveen Sharma; Martin Andrews; Kevin L Stephans; Carlos Oberti; Sara Lin; Oussama Wazni; Patrick Tchou; Walid I Saliba; John Suh
Journal:  Cureus       Date:  2016-07-11

6.  Analysis of Left Atrial Respiratory and Cardiac Motion for Cardiac Ablation Therapy.

Authors:  M E Rettmann; D R Holmes; S B Johnson; H I Lehmann; R A Robb; D L Packer
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-02-21

7.  Dosimetric feasibility of stereotactic ablative radiotherapy in pulmonary vein isolation for atrial fibrillation using intensity-modulated proton therapy.

Authors:  Xue-Ying Ren; Peng-Kang He; Xian-Shu Gao; Zhi-Lei Zhao; Bo Zhao; Yun Bai; Si-Wei Liu; Kang Li; Shang-Bin Qin; Ming-Wei Ma; Jing Zhou; Yi Rong
Journal:  J Appl Clin Med Phys       Date:  2021-04-04       Impact factor: 2.102

8.  Early Changes in Rat Heart After High-Dose Irradiation: Implications for Antiarrhythmic Effects of Cardiac Radioablation.

Authors:  Myung-Jin Cha; Jeong-Wook Seo; Hak Jae Kim; Moo-Kang Kim; Hye-Sun Yoon; Seong Won Jo; Seil Oh; Ji Hyun Chang
Journal:  J Am Heart Assoc       Date:  2021-03-04       Impact factor: 5.501

9.  Proof-of-concept for x-ray based real-time image guidance during cardiac radioablation.

Authors:  Nicholas Hindley; Suzanne Lydiard; Chun-Chien Shieh; Paul Keall
Journal:  Phys Med Biol       Date:  2021-08-24       Impact factor: 3.609

10.  Case Report: Treatment Planning Study to Demonstrate Feasibility of Transthoracic Ultrasound Guidance to Facilitate Ventricular Tachycardia Ablation With Protons.

Authors:  Rosalind Perrin; Patrick Maguire; Adriano Garonna; Georg Weidlich; Shelley Bulling; Marie Fargier-Voiron; Cedric De Marco; Eleonora Rossi; Mario Ciocca; Viviana Vitolo; Alfredo Mirandola
Journal:  Front Cardiovasc Med       Date:  2022-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.